The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Are Mast Cells MASTers in Cancer?
Open accessAbstract
Prolonged low-grade inflammation or smoldering inflammation is a hallmark of cancer. Mast cells form a heterogeneous population of immune cells with differences in their ultra-structure, morphology, mediator content, and surface receptors. Mast cells are widely distributed throughout all tissues and are stromal components of the inflammatory microenvironment that modulates tumor initiation and development. Although canonically associated with allergic disorders, mast cells are a major source of pro-tumorigenic (e.g., angiogenic and lymphangiogenic factors) and antitumorigenic molecules (e.g., TNF-α and IL-9), depending on the milieu. In certain neoplasias (e.g., gastric, thyroid and Hodgkin's lymphoma) mast cells play a pro-tumorigenic role, in others (e.g., breast cancer) a protective role, whereas in yet others they are apparently innocent bystanders. These seemingly conflicting results suggest that the role of mast cells and their mediators could be cancer specific. The microlocalization (e.g., peritumoral vs intratumoral) of mast cells is another important aspect in the initiation/progression of solid and hematologic tumors. Increasing evidence in certain experimental models indicates that targeting mast cells and/or their mediators represent a potential therapeutic target in cancer. Thus, mast cells deserve focused consideration also as therapeutic targets in different types of tumors. There are many unanswered questions that should be addressed before we understand whether mast cells are an ally, adversary, or innocent bystanders in human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“Prolonged low-grade inflammation or smoldering inflammation is a hallmark of cancer (27, 28).”
BackgroundMutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, J. M., Garcia-Diaz, A., Shin, D. S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D. Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604958 · Cited by 3,237
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
Zheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
IgE and mast cells in allergic disease
Galli, S. J., & Tsai, M. (2012) · Nature Medicine · doi:10.1038/nm.2755 · Cited by 1,799
Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Bissell, M. J., & Hines, W. C. (2011) · Nature Medicine · doi:10.1038/nm.2328 · Cited by 1,517
Gene-Expression Signatures in Breast Cancer
Sotiriou, C., & Pusztai, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801289 · Cited by 1,485
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Tumour heterogeneity in the clinic
Bedard, P. L., Hansen, A. R., Ratain, M. J., & Siu, L. L. (2013) · Nature · doi:10.1038/nature12627 · Cited by 1,211
Lactate: A Metabolic Key Player in Cancer
Hirschhaeuser, F., Sattler, U. G. A., & Mueller-Klieser, W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1457 · Cited by 1,090
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Coussens, L. M., Zitvogel, L., & Palucka, A. K. (2013) · Science · doi:10.1126/science.1232227 · Cited by 1,079
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 3×
“Skin Chloroacetate esterase/hematoxylin (98)”
BackgroundMethodMast Cell: A Multi-Functional Master Cell
Krystel-Whittemore, M., Dileepan, K. N., & Wood, J. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00620 · Cited by 890
Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links
Scheel, C., & Weinberg, R. A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.001 · Cited by 881
Zitvogel, L., Galluzzi, L., Smyth, M. J., & Kroemer, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.014 · Cited by 870
“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792 · cited 1×
“It has been shown that it is possible to reverse the immunosuppressive and pro-tumoral properties of tumorassociated macrophages (186, 187).”
BackgroundFolkman, J., & Shing, Y. (1992) · PubMed · Cited by 789
Cellular markers that distinguish the phases of hemangioma during infancy and childhood.
Takahashi, K., Mulliken, J. B., Kozakewich, H. P., Rogers, R. A., Folkman, J., & Ezekowitz, R. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117241 · Cited by 648
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Eruslanov, E. B., Bhojnagarwala, P. S., Quatromoni, J. G., Stephen, T. L., Ranganathan, A., Deshpande, C., Akimova, T., Vachani, A., Litzky, L., Hancock, W. W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77053 · Cited by 644
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
Kleffel, S., Posch, C., Barthel, S. R., Mueller, H., Schlapbach, C., Guenova, E., Elco, C. P., Lee, N., Juneja, V. R., Zhan, Q., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.052 · Cited by 639
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
Andreu, P., Johansson, M., Affara, N. I., Pucci, F., Tan, T., Junankar, S., Korets, L., Lam, J., Tawfik, D., DeNardo, D. G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.019 · Cited by 590
The anticancer immune response: indispensable for therapeutic success?
Zitvogel, L., Apetoh, L., Ghiringhelli, F., André, F., Tesniere, A., & Kroemer, G. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35180 · Cited by 573
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Harper, S. J., & Bates, D. O. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2505 · Cited by 514
Alarmins: awaiting a clinical response
Chan, J. K., Roth, J., Oppenheim, J. J., Tracey, K. J., Vogl, T., Feldmann, M., Horwood, N., & Nanchahal, J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62423 · Cited by 511
Soucek, L., Lawlor, E. R., Soto, D., Shchors, K., Swigart, L. B., & Evan, G. I. (2007) · Nature Medicine · doi:10.1038/nm1649 · Cited by 507
Robust tumor immunity to melanoma mediated by interleukin-9–producing T cells
Purwar, R., Schlapbach, C., Xiao, S., Kang, H. S., Elyaman, W., Jiang, X., Jetten, A. M., Khoury, S. J., Fuhlbrigge, R. C., Kuchroo, V. K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2856 · Cited by 442
Tumor associated macrophages and neutrophils in tumor progression
Galdiero, M. R., Garlanda, C., Jaillon, S., Marone, G., & Mantovani, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24260 · Cited by 440
Self-citationKirshenbaum, A. S., Goff, J. P., Semere, T., Foster, B., Scott, L. M., & Metcalfe, D. D. (1999) · Blood · doi:10.1182/blood.v94.7.2333.419k30_2333_2342 · Cited by 420
Nakae, S., Suto, H., Iikura, M., Kakurai, M., Sedgwick, J. D., Tsai, M., & Galli, S. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2238 · Cited by 412
Targeting Epigenetic Readers in Cancer
Dawson, M. A., Kouzarides, T., & Huntly, B. J. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1112635 · Cited by 397
Welsh, T. J., Green, R. H., Richardson, D., Waller, D. A., O'Byrne, K. J., & Bradding, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4910 · Cited by 369
Huang, B., Lei, Z., Zhang, G.-M., Li, D., Song, C., Li, B., Liu, Y., Yuan, Y., Unkeless, J., Xiong, H., et al. (2008) · Blood · doi:10.1182/blood-2008-03-147033 · Cited by 345
Grützkau, A., Krüger-Krasagakes, S., Baumeister, H., Schwarz, C., Kögel, H., Welker, P., Lippert, U., Henz, B. M., & Möller, A. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.4.875 · Cited by 337
Boesiger, J., Tsai, M., Maurer, M., Yamaguchi, M., Brown, L. F., Claffey, K. P., Dvorak, H. F., & Galli, S. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1135 · Cited by 336
Feyerabend, T. B., Weiser, A., Tietz, A., Stassen, M., Harris, N., Kopf, M., Radermacher, P., Möller, P., Benoist, C., Mathis, D., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.015 · Cited by 335
Duluc, D., Corvaisier, M., Blanchard, S., Catala, L., Descamps, P., Gamelin, E., Ponsoda, S., Delneste, Y., Hebbar, M., & Jeannin, P. (2009) · International Journal of Cancer · doi:10.1002/ijc.24401 · Cited by 329
Theoharides, T. C., Zhang, B., Kempuraj, D., Tagen, M., Vasiadi, M., Angelidou, A., Alysandratos, K.-D., Kalogeromitros, D., Asadi, S., Stavrianeas, N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000803107 · Cited by 318
Cancer Inflammation and Cytokines
Galdiero, M. R., Marone, G., & Mantovani, A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028662 · Cited by 267
Self-citationTumor vascularity and tryptase‐positive mast cells correlate with a poor prognosis in melanoma
Ribatti, D., Ennas, M. G., Vacca, A., Ferreli, F., Nico, B., Orru, S., & Sirigu, P. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01152.x · Cited by 262
Esposito, I., Menicagli, M., Funel, N., Bergmann, F., Boggi, U., Mosca, F., Bevilacqua, G., & Campani, D. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.014498 · Cited by 257
Mast cells are an essential hematopoietic component for polyp development
Gounaris, E., Erdman, S. E., Restaino, C., Gurish, M. F., Friend, D. S., Gounari, F., Lee, D. M., Zhang, G., Glickman, J. N., Shin, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704620104 · Cited by 251
Ribatti, D., Vacca, A., Nico, B., Quondamatteo, F., Ria, R., Minischetti, M., Marzullo, A., Herken, R., Roncali, L., & Dammacco, F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690070 · Cited by 247
Widespread Immunological Functions of Mast Cells: Fact or Fiction?
Rodewald, H.-R., & Feyerabend, T. B. (2012) · Immunity · doi:10.1016/j.immuni.2012.07.007 · Cited by 240
Subramanian, H., Gupta, K., Guo, Q., Price, R., & Ali, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277152 · Cited by 239
Baram, D., Vaday, G. G., Salamon, P., Drucker, I., Hershkoviz, R., & Mekori, Y. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.4008 · Cited by 233
Yang, X. D., Ai, W., Asfaha, S., Bhagat, G., Friedman, R. A., Jin, G., Park, H., Shykind, B., Diacovo, T. G., Falus, A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2278 · Cited by 233
Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma
Takanami, I., Takeuchi, K., & Naruke, M. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2686::aid-cncr6>3.0.co;2-6 · Cited by 231
Varey, A. H. R., Rennel, E. S., Qiu, Y., Bevan, H. S., Perrin, R. M., Raffy, S., Dixon, A. R., Paraskeva, C., Zaccheo, O., Hassan, A. B., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604308 · Cited by 226
Mast cells have a protumorigenic role in human thyroid cancer
Melillo, R. M., Guarino, V, Avilla, E., Galdiero, M. R., Liotti, F., Prevete, N., Rossi, F. W., Basolo, F., Ugolini, C., de Paulis, A., et al. (2010) · Oncogene · doi:10.1038/onc.2010.348 · Cited by 219
Self-citationJohansson, A., Rudolfsson, S., Hammarsten, P., Halin, S., Pietras, K., Jones, J., Stattin, P., Egevad, L., Granfors, T., Wikström, P., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100070 · Cited by 216
Rajput, A. B., Turbin, D. A., Cheang, M. C., Voduc, D. K., Leung, S., Gelmon, K. A., Gilks, C. B., & Huntsman, D. G. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9546-3 · Cited by 216
AllergoOncology: the role of IgE‐mediated allergy in cancer
Jensen‐Jarolim, E., Achatz, G., Turner, M. C., Karagiannis, S., Legrand, F., Capron, M., Penichet, M. L., Rodríguez, J. A., Siccardi, A. G., Vangelista, L., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01768.x · Cited by 216
Palm, N. W., Rosenstein, R. K., Yu, S., Schenten, D. D., Florsheim, E., & Medzhitov, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.006 · Cited by 214
Visciano, C., Liotti, F., Prevete, N., Cali', G., Franco, R., Collina, F., de Paulis, A., Marone, G., Santoro, M., & Melillo, R. M. (2015) · Oncogene · doi:10.1038/onc.2014.441 · Cited by 214
Self-citationRedefinition of the human mast cell transcriptome by deep-CAGE sequencing
Motakis, E., Guhl, S., Ishizu, Y., Itoh, M., Kawaji, H., de Hoon, M., Lassmann, T., Carninci, P., Hayashizaki, Y., Zuberbier, T., et al. (2014) · Blood · doi:10.1182/blood-2013-02-483792 · Cited by 210
Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects
Detoraki, A., Staiano, R. I., Granata, F., Giannattasio, G., Prevete, N., de Paulis, A., Ribatti, D., Genovese, A., Triggiani, M., & Marone, G. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.01.044 · Cited by 208
Self-citationMast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma
Molin, D., Edström, A., Glimelius, I., Glimelius, B., Nilsson, G., Sundström, C., & Enblad, G. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03768.x · Cited by 203
Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression
Strouch, M. J., Cheon, E. C., Salabat, M. R., Krantz, S. B., Gounaris, E., Melstrom, L. G., Dangi-Garimella, S., Wang, E., Munshi, H. G., Khazaie, K., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1230 · Cited by 199
Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma
Imada, A., Shijubo, N., Kojima, H., & Abe, S. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.01517.x · Cited by 195
Dynamic Mast Cell–Stromal Cell Interactions Promote Growth of Pancreatic Cancer
Ma, Y., Hwang, R. F., Logsdon, C. D., & Ullrich, S. E. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4479 · Cited by 186
A beneficial role for immunoglobulin E in host defense against honeybee venom
Marichal, T., Starkl, P., Reber, L. L., Kalesnikoff, J., Oettgen, H. C., Tsai, M., Metz, M., & Galli, S. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.005 · Cited by 180
Mast cells as targets for immunotherapy of solid tumors
Oldford, S. A., & Marshall, J. S. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.02.020 · Cited by 179
Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors
Weller, C. L., Collington, S. J., Brown, J. K., Miller, H. R. P., Al‐Kashi, A., Clark, P., Jose, P. J., Hartnell, A., & Williams, T. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042407 · Cited by 175
Vascular Endothelial Growth Factor-B in Physiology and Disease
Bry, M., Kivelä, R., Leppänen, V.-M., & Alitalo, K. (2014) · Physiological Reviews · doi:10.1152/physrev.00028.2013 · Cited by 173
New models for analyzing mast cell functions in vivo
Reber, L. L., Marichal, T., & Galli, S. J. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.09.008 · Cited by 171
Tumor lymphangiogenesis and melanoma metastasis
Rinderknecht, M., & Detmar, M. J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21494 · Cited by 169
Angiogenesis and lymphangiogenesis in inflammatory skin disorders
Varricchi, G., Granata, F., Loffredo, S., Genovese, A., & Marone, G. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.03.041 · Cited by 168
Self-citationAbdel-Majid, R. M., & Marshall, J. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1227 · Cited by 165
T[oacute]th, T. (2000) · Human Pathology · doi:10.1053/hupa.2000.16658 · Cited by 165
Gulubova, M., & Vlaykova, T. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05009.x · Cited by 162
Mulero, I., Sepulcre, M. P., Meseguer, J., Ayala, A. G., & Mulero, V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704535104 · Cited by 161
Monte, L. B. D., Wörmann, S. M., Brunetto, E., Heltai, S., Magliacane, G., Reni, M., Paganoni, A. M., Recalde, H. R., Mondino, A., Falconi, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1801-t · Cited by 161
Adenosine release from stimulated mast cells.
Marquardt, D. L., Gruber, H. E., & Wasserman, S. I. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.19.6192 · Cited by 155
Mast cell–derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors
Nakayama, T., Yao, L., & Tosato, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22089 · Cited by 151
Oldford, S. A., Haidl, I. D., Howatt, M., Leiva, C., Johnston, B., & Marshall, J. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001137 · Cited by 148
Ribatti, D., Vacca, A., Ria, R., Marzullo, A., Nico, B., Filotico, R., Roncali, L., & Dammacco, F. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00150-8 · Cited by 146
Dabiri, S., Huntsman, D. D., Makretsov, N. A., Cheang, M. C. U., Gilks, C. B., Badjik, C., Gelmon, K. A., Chia, S., & Hayes, M. (2004) · Modern Pathology · doi:10.1038/modpathol.3800094 · Cited by 146
Pittoni, P., Tripodo, C., Piconese, S., Mauri, G., Parenza, M., Rigoni, A., Sangaletti, S., & Colombo, M. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1637 · Cited by 146
Adenosine Potentiates Mediator Release from Human Lung Mast Cells
Peachell, P. T., Columbo, M., Kagey-Sobotka, A., Lichtenstein, L. M., & Marone, G. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.5.1143 · Cited by 144
Self-citationMast Cells in Tumor Microenvironment Promotes the In Vivo Growth of Pancreatic Ductal Adenocarcinoma
Chang, D. Z., Ma, Y., Ji, B., Wang, H., Deng, D., Liu, Y., Abbruzzese, J. L., Liu, Y., Logsdon, C. D., & Hwu, P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0607 · Cited by 144
Fleischmann, A., Schlomm, T., Köllermann, J. W., Sekulić, N., Huland, H., Mirlacher, M., Sauter, G., Simon, R., & Erbersdobler, A. (2009) · The Prostate · doi:10.1002/pros.20948 · Cited by 141
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
Riquelme, I., Saavedra, K., Espinoza, J. A., Weber, H. L., García, P., Nervi, B., Marcelo Garrido, S., Corvalán, A. H., Roa, J. C., & Bizama, C. (2015) · Oncotarget · doi:10.18632/oncotarget.4990 · Cited by 140
Chemotactic action of prostaglandin E 2 on mouse mast cells acting via the PGE 2 receptor 3
Weller, C. L., Collington, S. J., Hartnell, A., Conroy, D. M., Kaise, T., Barker, J. E., Wilson, M. S., Taylor, G. W., Jose, P. J., & Williams, T. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701700104 · Cited by 140
Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis
Marone, G., Varricchi, G., Loffredo, S., & Granata, F. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.088 · Cited by 139
Self-citationAngiogenesis and lymphangiogenesis in bronchial asthma
Detoraki, A., Granata, F., Staibano, S., Rossi, F. W., Marone, G., & Genovese, A. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02372.x · Cited by 135
Self-citationNonomura, N., Takayama, H., Nishimura, K., Oka, D., Nakai, Y., Shiba, M., Tsujimura, A., Nakayama, M., Aozasa, K., & Okuyama, Ä. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603962 · Cited by 133
Tournilhac, O., dos Santos, D. M., Xu, L., Kutok, J. L., Tai, Y., Gouill, S. L., Catley, L. P., Hunter, Z. R., Branagan, A. R., Boyce, J. A., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl109 · Cited by 133
Mast cells play a protumorigenic role in primary cutaneous lymphoma
Rabenhorst, A., Schlaak, M. S., Heukamp, L. C., Förster, A., Theurich, S., von Bergwelt‐Baildon, M., Büttner, R., Kurschat, P., Mauch, C., Roers, A., et al. (2012) · Blood · doi:10.1182/blood-2012-03-415638 · Cited by 130
Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis
Yano, H., Kinuta, M., Tateishi, H., Nakano, Y., Matsui, S., Monden, T., Okamura, J., Sakai, M., & Okamoto, S. (1999) · Gastric Cancer · doi:10.1007/s101200050017 · Cited by 129
Byrne, S. N., Beaugie, C., O’Sullivan, C., Leighton, S., & Halliday, G. M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.010 · Cited by 126
Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma
Kim, S. Y., Kim, S., Hahn, H. J., Lee, Y. W., Choe, Y. B., & Ahn, K. J. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.02.1113 · Cited by 126
Tumor metabolism as modulator of immune response and tumor progression
Gottfried, E., Kreutz, M. P., & Mackensen, A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.009 · Cited by 125
Granata, F., Frattini, A., Loffredo, S., Staiano, R. I., Petraroli, A., Ribatti, D., Oslund, R., Gelb, M. H., Lambeau, G. J., Marone, G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902501 · Cited by 124
Self-citationProstaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation
Kay, L. J., Yeo, W. W., & Peachell, P. T. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706664 · Cited by 118
Histamine Release from Mast Cells and Basophils
Borriello, F., Iannone, R., & Marone, G. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_18 · Cited by 116
Self-citationMast Cells in Basal Cell Carcinoma Express VEGF, IL-8 and RANTES
Mikako, A. O. K. I., Pawankar, R., Niimi, Y., & Kawana, S. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000069515 · Cited by 115
Mast cells mediate malignant pleural effusion formation
Giannou, A. D., Marazioti, A., Σπέλλα, Μ., Kanellakis, N. I., Apostolopoulou, H., Psallidas, I., Prijovich, Z. M., Vreka, M., Zazara, D. E., Lilis, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79840 · Cited by 111
H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12
Godot, V., Arock, M., Garcia, G., Capel, F., Flys, C., Dy, M., Émilie, D., & Humbert, M. J. C. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.05.046 · Cited by 110
Okayama, Y., Hagaman, D. D., & Metcalfe, D. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4705 · Cited by 109
Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer
Tan, S.-Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i8.1210 · Cited by 108
A protective role of mast cells in intestinal tumorigenesis
Sinnamon, M. J., Carter, K. J., Sims, L. P., LaFleur, B., Fingleton, B., & Matrisian, L. M. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn040 · Cited by 108
Immune and inflammatory cell composition of human lung cancer stroma
Banat, G.-A., Tretyn, A., Pullamsetti, S. S., Wilhelm, J., Weigert, A., Olesch, C., Ebel, K., Stiewe, T., Grimminger, F., Seeger, W., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139073 · Cited by 107
Epidemiological associations of allergy, IgE and cancer
Josephs, D. H., Spicer, J. F., Corrigan, C. J., Gould, H. J., & Karagiannis, S. N. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12178 · Cited by 105
Stem Cell Factor Is Localized in, Released from, and Cleaved by Human Mast Cells
de Paulis, A., Minopoli, G., Arbustini, E., de Crescenzo, G., Piaz, F. D., Pucci, P., Russo, T., & Marone, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2799 · Cited by 104
Self-citationTumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas
Acikalin, M. F., Öner, Ü., Topçu, İ., Yaşar, B., Kiper, H., & Çolak, E. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.09.028 · Cited by 103
Mancardi, D. A., Jönsson, F., Iannascoli, B., Khun, H., van Rooijen, N., Huerre, M., Daëron, M., & Bruhns, P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003642 · Cited by 102
Nagasaka, A., Matsue, H., Matsushima, H., Aoki, R., Nakamura, Y., Kambe, N., Kon, S., Uede, T., & Shimada, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200737057 · Cited by 102
Malfettone, A., Silvestris, N., Saponaro, C., Ranieri, G., Russo, A. D., Caruso, S., Popescu, O., Simone, G., Paradiso, A., & Mangia, A. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12073 · Cited by 102
Wang, Z., Lai, Y., Bernard, J. J., MacLeod, D. T., Cogen, A. L., Moss, B., & Nardo, A. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101703 · Cited by 102
HIF-1α Is Up-Regulated in Activated Mast Cells by a Process That Involves Calcineurin and NFAT
Walczak‐Drzewiecka, A., Ratajewski, M., Wagner, W., & Dastych, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1665 · Cited by 100
AllergoOncology – the impact of allergy in oncology: EAACI position paper
Jensen‐Jarolim, E., Bax, H. J., Bianchini, R., Capron, M., Corrigan, C. J., Castells, M., Dombrowicz, D., Daniels‐Wells, T. R., Fazekas, J., Fiebiger, E., et al. (2016) · Allergy · doi:10.1111/all.13119 · Cited by 99
Marone, G., Galli, S. J., & Kitamura, Y. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02274-3 · Cited by 97
Self-citationMast Cells Have Prognostic Value in Merkel Cell Carcinoma
Beer, T. W., Ng, L., & Murray, K. (2008) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e31815c932a · Cited by 95
Li, L., Dang, Q., Xie, H., Yang, Z., He, D., Liang, L., Song, W., Yeh, S., & Chang, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3651 · Cited by 95
Rao, Q. X., Chen, Y., Yeh, C., Ding, J., Li, L., Chang, C., & Yeh, S. (2015) · Oncotarget · doi:10.18632/oncotarget.5467 · Cited by 95
Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer
Chan, J. K., Magistris, A., Loizzi, V., Lin, F., Rutgers, J. K. L., Osann, K., DiSaia, P. J., & Samoszuk, M. K. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.05.042 · Cited by 93
Association of Mast Cells with Microvessel Density in Renal Cell Carcinomas
Tuna, B., Yörükoğlu, K., Ünlü, M., Mungan, M. U., & Kırkalı, Z. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.040 · Cited by 90
Sismanopoulos, N., Delivanis, D. A., Alysandratos, K., Angelidou, A., Vasiadi, M., Therianou, A., & Theoharides, T. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033271 · Cited by 89
Genovese, A., Borgia, G., Björck, L., Petraroli, A., de Paulis, A., Piazza, M., & Marone, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1854 · Cited by 88
Self-citationMast cells and eosinophils in invasive breast carcinoma
Amini, R., Aaltonen, K., Nevanlinna, H. A., Carvalho, R. F. D. S., Salonen, L., Heikkilä, P., & BLOMQVIST, C. P. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-165 · Cited by 86
Tripodo, C., Gri, G., Piccaluga, P. P., Frossi, B., Guarnotta, C., Piconese, S., Franco, G. M., Vetri, V., Pucillo, C. E. M., Florena, A. M., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091286 · Cited by 85
Cai, S., Yang, S., Gao, J., Pan, K., Chen, J.-Y., Wang, Y., Wei, L., & Dong, J. (2010) · Surgery · doi:10.1016/j.surg.2010.10.009 · Cited by 82
Mast Cells Condition Dendritic Cells to Mediate Allograft Tolerance
de Vries, V. C., Pino‐Lagos, K., Nowak, E. C., Bennett, K. A., Oliva, C., & Noelle, R. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.012 · Cited by 79
Mast cell infiltration is a favourable prognostic factor in diffuse large B‐cell lymphoma
Hedström, G., Berglund, M., Molin, D. L., Fischer, M., Nilsson, G. P., Thunberg, U., Book, M., Sundström, C., Rosenquist, R., Roos, G., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06612.x · Cited by 79
Mast cell phenotypes and microvessels in non‐small cell lung cancer and its prognostic significance
Carlini, M. J., Dalurzo, M. C. L., Lastiri, J. M., Smith, D. E., Vasallo, B. C., Puricelli, L. I., & Lauría de Cidre, L. S. (2010) · Human Pathology · doi:10.1016/j.humpath.2009.04.029 · Cited by 79
Siiskonen, H., Poukka, M., Bykachev, A., Tyynelä-Korhonen, K., Sironen, R. K., Pasonen‐Seppänen, S., & Harvima, I. T. (2015) · Melanoma Research · doi:10.1097/cmr.0000000000000192 · Cited by 79
Loffredo, S., Borriello, F., Iannone, R., Ferrara, A. L., Galdiero, M. R., Gigantino, V., Esposito, P. B., Varricchi, G., Lambeau, G. J., Cassatella, M. A., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00443 · Cited by 79
Self-citationControversial role of mast cells in skin cancers
Varricchi, G., Galdiero, M. R., Marone, G., Granata, F., Borriello, F., & Marone, G. (2016) · Experimental Dermatology · doi:10.1111/exd.13107 · Cited by 78
Self-citationPlatzer, B., Elpek, K. G., Cremasco, V., Baker, K., Stout, M., Schultz, C., Dehlink, E., Shade, K.-T., Anthony, R. M., Blumberg, R. S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.015 · Cited by 77
Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization
de Paulis, A., Marinò, I., Ciccarelli, A., de Crescenzo, G., Concardi, M., Verga, L., Arbustini, E., & Marone, G. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390723 · Cited by 77
Self-citationChichlowski, M., Westwood, G. S., Abraham, S. N., & Hale, L. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012220 · Cited by 76
Mast cells are dispensable for normal and activin‐promoted wound healing and skin carcinogenesis
Antsiferova, M., Martin, C., Huber, M., Feyerabend, T. B., Förster, A., Hartmann, K., Rodewald, H.-R., Hohl, D., & Werner, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301350 · Cited by 75
Johnson, C., Huynh, V. D., Hargrove, L. A., Kennedy, L. L., Graf, A. B., Owens, J., Trzeciakowski, J. P., Hodges, K., DeMorrow, S., Han, Y., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.09.016 · Cited by 74
Nordlund, J. J., & Askenase, P. W. (1983) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12538356 · Cited by 73
Rovere, F., Granata, A., Familiari, D., D’Arrigo, G., Mondello, B., & Basile, G. (2007) · PubMed · Cited by 72
Taskinen, M., Karjalainen‐Lindsberg, M., & Leppä, S. (2008) · Blood · doi:10.1182/blood-2007-11-125823 · Cited by 70
Ammendola, M., Sacco, R., Donato, G., Zuccalà, V., Russo, E., Luposella, M., Vescio, G., Rizzuto, A., Patruno, R., Sarro, G. D., et al. (2013) · Oncology · doi:10.1159/000351145 · Cited by 69
Mast Cell Survival and Mediator Secretion in Response to Hypoxia
Gulliksson, M., Carvalho, R. F., Ullerås, E., & Nilsson, G. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012360 · Cited by 69
Tumor-Associated Mast Cells in Thyroid Cancer
Visciano, C., Prevete, N., Liotti, F., & Marone, G. (2015) · International Journal of Endocrinology · doi:10.1155/2015/705169 · Cited by 68
Self-citationThe critical role of mast cell‐derived hypoxia‐inducible factor‐1α in human and mice melanoma growth
Jeong, H., Oh, H., Nam, S., Han, N., Kim, Y., Kim, J., Lee, S., Kim, M., Moon, P., Kim, H., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27937 · Cited by 67
Wedemeyer, J., & Galli, S. J. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700232 · Cited by 66
Ammendola, M., Sacco, R., Sammarco, G., Donato, G., Montemurro, S., Ruggieri, E., Patruno, R., Marech, I., Cariello, M., Vacca, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099512 · Cited by 63
Modeling Pharmacological Inhibition of Mast Cell Degranulation as a Therapy for Insulinoma
Soucek, L., Buggy, J. J., Kortlever, R. M., Adimoolam, S., Allende, H., Salcedo, M. T., Swigart, L. B., & Evan, G. I. (2011) · Neoplasia · doi:10.1593/neo.11980 · Cited by 62
Sarchio, S. N. E., Scolyer, R. A., Beaugie, C., McDonald, D. M., Marsh‐Wakefield, F., Halliday, G. M., & Byrne, S. N. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.424 · Cited by 61
Rivellese, F., Suurmond, J., Habets, K. L. L., Dorjée, A. L., Ramamoorthi, N., Townsend, M. J., de Paulis, A., Marone, G., Huizinga, T. W. J., Pitzalis, C., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39192 · Cited by 60
Self-citationThe Dark Side of Mast Cell–Targeted Therapy in Prostate Cancer
Pittoni, P., & Colombo, M. P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3110 · Cited by 59
Expression of chymase‐positive cells in gastric cancer and its correlation with the angiogenesis
Kondo, K., Muramatsu, M., Okamoto, Y., Jin, D., Takai, S., Tanigawa, N., & Miyazaki, M. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20394 · Cited by 58
Tumor angiogenesis of non–small cell lung cancer
Shijubo, N., Kojima, H., Nagata, M., Ohchi, T., Suzuki, A., Abe, S., & Sato, N. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10257 · Cited by 53
Molecular testing in lung cancer in the era of precision medicine.
Popper, H., Ryška, A., Tímár, J., & Olszewski, W. T. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2014.10.01 · Cited by 52
Mast cell phenotype, TNFα expression and degranulation status in non-small cell lung cancer
Shikotra, A., Ohri, C. M., Green, R. H., Waller, D. A., & Bradding, P. H. (2016) · Scientific Reports · doi:10.1038/srep38352 · Cited by 51
Chacón‐Salinas, R., Chen, L., Chávez-Blanco, A. D., Limón-Flores, A. Y., Ma, Y., & Ullrich, S. E. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811409 · Cited by 50
Xie, H., Li, C., Dang, Q., Chang, L. S., & Li, L. (2016) · Oncotarget · doi:10.18632/oncotarget.6372 · Cited by 49
Tu, J.-F., Pan, H., Ying, X.-H., Jian, L., Ji, J.-S., & Zou, H. (2016) · Medicine · doi:10.1097/md.0000000000003220 · Cited by 49
Dündar, E., Oner, U., Peker, B. C., Metintaş, M., Işıksoy, S., & Ak, G. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600112 · Cited by 48
Plasticity in mast cell responses during bacterial infections
Chan, C. Y., John, A. L. S., & Abraham, S. N. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.10.007 · Cited by 46
Expression of stem cell factor in basal cell carcinoma
Yamamoto, T., Katayama, I., & Nishioka, K. (1997) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1997.tb01106.x · Cited by 45
Ammendola, M., Sacco, R., Sammarco, G., Donato, G., Zuccalà, V., Romano, R., Luposella, M., Patruno, R., Vallicelli, C., Verdecchia, G. M., et al. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/703163 · Cited by 45
Franco, G. M., Guarnotta, C., Frossi, B., Piccaluga, P. P., Boveri, E., Gulino, A., Fuligni, F., Rigoni, A., Porcasi, R., Buffa, S., et al. (2014) · Blood · doi:10.1182/blood-2013-04-497271 · Cited by 44
Tan, S., Chen, D., Liu, K., He, M., Song, H., Shi, Y., Liu, J., Zhang, C. W.-H., Qi, J., Yan, J., et al. (2016) · Protein & Cell · doi:10.1007/s13238-016-0337-7 · Cited by 43
Suzuki, S., Ichikawa, Y., Nakagawa, K., Kumamoto, T., Mori, R., Matsuyama, R., Takeda, K., Ota, M., Tanaka, K., Tamura, T., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1863-z · Cited by 42
Mast cells impair the development of protective anti-tumor immunity
Wasiuk, A., Dalton, D. K., Schpero, W. L., Stan, R. V., Conejo-Garcia, J. R., & Noelle, R. J. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1276-7 · Cited by 42
Kormelink, T. G., Powe, D. G., Kuijpers, S. A., Abudukelimu, A., Fens, M. H. A. M., Pieters, E. H. E., der Ven, W. W. K.-V., Habashy, H. O., Ellis, I. O., Blokhuis, B. R. J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1868 · Cited by 42
SDF-1 Induces IL-8 Production and Transendothelial Migration of Human Cord Blood-Derived Mast Cells
Lin, T., Issekutz, T. B., & Marshall, J. S. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000053693 · Cited by 40
Lundström, S. L., Saluja, R., Mikael Adner, A., Haeggström, J. Z., Nilsson, G. P., & Wheelock, C. E. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m030171 · Cited by 38
Tryptase Mast Cells in Malignant Pleural Mesothelioma as an Independent Favorable Prognostic Factor
Alì, G., Boldrini, L., Lucchi, M., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181989ddb · Cited by 36
Fakhrjou, A., Niroumand-Oscoei, S. M., Somi, M. H., Ghojazadeh, M., Naghashi, S., & Samankan, S. (2013) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-013-9550-2 · Cited by 35
Xia, Q., Wu, X.-J., Zhou, Q., Jing-Zeng, Hou, J.-H., Pan, Z.-Z., & Zhang, X.-S. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-88 · Cited by 34
Siebenhaar, F., Metz, M., & Maurer, M. (2014) · Experimental Dermatology · doi:10.1111/exd.12328 · Cited by 34
Jiménez-Andrade, G. Y., Ibarra-Sánchez, A., González, D., Lamas, M., & González‐Espinosa, C. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-56 · Cited by 33
Hölzel, M., Landsberg, J., Glodde, N., Bald, T., Rogava, M., Riesenberg, S., Becker, A. J., Jonsson, G. G., & Tüting, T. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1090 · Cited by 33
Englund, A., Molin, D. L., Enblad, G., Karlén, J., Glimelius, I. C., Ljungman, G., & Amini, R. (2016) · European Journal Of Haematology · doi:10.1111/ejh.12747 · Cited by 29
Beiträge zur Kenntniss der granulirten Bindegewebszellen und der eosinophilen Leukocythen
(2013) · Elsevier eBooks · doi:10.1016/b978-0-08-009054-2.50011-0 · Cited by 28
Über die specifischen Granulationen des Blutes
(2013) · Elsevier eBooks · doi:10.1016/b978-0-08-009054-2.50012-2 · Cited by 26
The Impact of Mast Cell Density on the Progression of Bone Disease in Multiple Myeloma Patients
Vyzoukaki, R., Tsirakis, G., Pappa, C. A., Devetzoglou, M., Tzardi, M. N., & Alexandrakis, M. G. (2015) · International Archives of Allergy and Immunology · doi:10.1159/000443275 · Cited by 25
Granata, F., & Marone, G. (2013) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000352074 · Cited by 24
Self-citationInnate myeloid cells under the control of adaptive immunity: the example of mast cells and basophils
Daëron, M. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.12.004 · Cited by 22
Platelet-Activating Factor Induces Epigenetic Modifications in Human Mast Cells
Damiani, E., Puebla‐Osorio, N., Gorbea, E., & Ullrich, S. E. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.336 · Cited by 21
Wang, S., Li, L., Shi, R., Liu, X., Zhang, J., Zou, Z., Hao, Z., & Tao, A. (2016) · Toxins · doi:10.3390/toxins8030071 · Cited by 17
Cited by
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Liu, T., Han, C., Wang, S., Fang, P., Ma, Z., Xu, L., & Yin, R. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0770-1 · Cited by 860
“For example, mast cellderived IL-13 and adenosine might, respectively, promote M2 macrophage polarization and block the access of CD8 T cells [65, 66].”
BackgroundMast cells as sources of cytokines, chemokines, and growth factors
Mukai, K., Tsai, M., Saito, H., & Galli, S. J. (2018) · Immunological Reviews · doi:10.1111/imr.12634 · Cited by 682
Tumor Immunology and Tumor Evolution: Intertwined Histories
Galon, J., & Bruni, D. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.018 · Cited by 540
Albini, A., Bruno, A., Noonan, D. M., & Mortara, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00527 · Cited by 392
Metadata
- Authors
- Varricchi, G., Galdiero, M. R., Loffredo, S., Marone, G., Iannone, R., Marone, G., & Granata, F.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-04-12
- Volume
- 8
- Pages
- 424-424
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2606526654
- Cited by
- 323
- References
- 181
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.